These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 25017254)

  • 21. The SLC34A2-ROS-HIF-1-induced up-regulation of EZH2 expression promotes proliferation and chemo-resistance to apoptosis in colorectal cancer.
    Li X; Xing J; Wang H; Yu E
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30038060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypoxia-inducible factor-1alpha correlates with MET and metastasis in node-negative breast cancer.
    Chen HH; Su WC; Lin PW; Guo HR; Lee WY
    Breast Cancer Res Treat; 2007 Jun; 103(2):167-75. PubMed ID: 17028975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancer of zeste homolog 2 overexpression in nasopharyngeal carcinoma: an independent poor prognosticator that enhances cell growth.
    Hwang CF; Huang HY; Chen CH; Chien CY; Hsu YC; Li CF; Fang FM
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):597-604. PubMed ID: 21300475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of hypoxia-inducible factor-1alpha in human osteosarcoma: correlation with clinicopathological parameters and survival outcome.
    Yang QC; Zeng BF; Dong Y; Shi ZM; Jiang ZM; Huang J
    Jpn J Clin Oncol; 2007 Feb; 37(2):127-34. PubMed ID: 17237146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EZH2 is associated with poor prognosis in head-and-neck squamous cell carcinoma via regulating the epithelial-to-mesenchymal transition and chemosensitivity.
    Chang JW; Gwak SY; Shim GA; Liu L; Lim YC; Kim JM; Jung MG; Koo BS
    Oral Oncol; 2016 Jan; 52():66-74. PubMed ID: 26604082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EZH2 overexpression in different immunophenotypes of breast carcinoma and association with clinicopathologic features.
    Guo S; Li X; Rohr J; Wang Y; Ma S; Chen P; Wang Z
    Diagn Pathol; 2016 Apr; 11():41. PubMed ID: 27113214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer.
    Schindl M; Schoppmann SF; Samonigg H; Hausmaninger H; Kwasny W; Gnant M; Jakesz R; Kubista E; Birner P; Oberhuber G;
    Clin Cancer Res; 2002 Jun; 8(6):1831-7. PubMed ID: 12060624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Co-expression of Bmi1 and EZH2 as an independent poor prognostic factor in esophageal squamous cell carcinoma.
    Ha SY; Kim SH
    Pathol Res Pract; 2012 Aug; 208(8):462-9. PubMed ID: 22766604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-144 suppresses tumorigenesis and tumor progression of astrocytoma by targeting EZH2.
    Lin L; Zheng Y; Tu Y; Wang Z; Liu H; Lu X; Xu L; Yuan J
    Hum Pathol; 2015 Jul; 46(7):971-80. PubMed ID: 25907866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PGK1 is a Potential Survival Biomarker and Invasion Promoter by Regulating the HIF-1α-Mediated Epithelial-Mesenchymal Transition Process in Breast Cancer.
    Fu D; He C; Wei J; Zhang Z; Luo Y; Tan H; Ren C
    Cell Physiol Biochem; 2018; 51(5):2434-2444. PubMed ID: 30537744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relation between hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression with anemia and outcome in surgically treated head and neck cancer.
    Winter SC; Shah KA; Han C; Campo L; Turley H; Leek R; Corbridge RJ; Cox GJ; Harris AL
    Cancer; 2006 Aug; 107(4):757-66. PubMed ID: 16826581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thymosin β4 expression correlates with lymph node metastasis through hypoxia inducible factor-α induction in breast cancer.
    Yoon SY; Lee HR; Park Y; Kim JH; Kim SY; Yoon SR; Lee WJ; Cho BJ; Min H; Bang JW; Park H; Bang SI; Cho D
    Oncol Rep; 2011 Jan; 25(1):23-31. PubMed ID: 21109953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinctive expression of the polycomb group proteins Bmi1 polycomb ring finger oncogene and enhancer of zeste homolog 2 in nonsmall cell lung cancers and their clinical and clinicopathologic significance.
    Kikuchi J; Kinoshita I; Shimizu Y; Kikuchi E; Konishi J; Oizumi S; Kaga K; Matsuno Y; Nishimura M; Dosaka-Akita H
    Cancer; 2010 Jun; 116(12):3015-24. PubMed ID: 20564407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypoxia inducible factor-1alpha is a prognostic marker in premenopausal patients with intermediate to highly differentiated breast cancer but not a predictive marker for tamoxifen response.
    Kronblad A; Jirström K; Rydén L; Nordenskjöld B; Landberg G
    Int J Cancer; 2006 May; 118(10):2609-16. PubMed ID: 16381002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and prognostic relevance of EZH2 in breast cancer: A meta-analysis.
    Wang X; Hu B; Shen H; Zhou H; Xue X; Chen Y; Chen S; Han Y; Yuan B; Zhao H; Zhi Q; Kuang Y
    Biomed Pharmacother; 2015 Oct; 75():218-25. PubMed ID: 26271144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aurora-A activation, correlated with hypoxia-inducible factor-1α, promotes radiochemoresistance and predicts poor outcome for nasopharyngeal carcinoma.
    Wan XB; Fan XJ; Huang PY; Dong D; Zhang Y; Chen MY; Xiang J; Xu J; Liu L; Zhou WH; Lv YC; Wu XY; Hong MH; Liu Q
    Cancer Sci; 2012 Aug; 103(8):1586-94. PubMed ID: 22587416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Global H3K27 trimethylation and EZH2 abundance in breast tumor subtypes.
    Holm K; Grabau D; Lövgren K; Aradottir S; Gruvberger-Saal S; Howlin J; Saal LH; Ethier SP; Bendahl PO; Stål O; Malmström P; Fernö M; Rydén L; Hegardt C; Borg Å; Ringnér M
    Mol Oncol; 2012 Oct; 6(5):494-506. PubMed ID: 22766277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypoxia-inducible factor 1α in breast cancer prognosis.
    Wang W; He YF; Sun QK; Wang Y; Han XH; Peng DF; Yao YW; Ji CS; Hu B
    Clin Chim Acta; 2014 Jan; 428():32-7. PubMed ID: 24482805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypoxia-inducible factor-2alpha correlates to distant recurrence and poor outcome in invasive breast cancer.
    Helczynska K; Larsson AM; Holmquist Mengelbier L; Bridges E; Fredlund E; Borgquist S; Landberg G; Påhlman S; Jirström K
    Cancer Res; 2008 Nov; 68(22):9212-20. PubMed ID: 19010893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of enhancer of zeste homolog 2 (EZH2) and focal adhesion kinase (FAK) in high grade endometrial carcinoma.
    Zhou J; Roh JW; Bandyopadhyay S; Chen Z; Munkarah AR; Hussein Y; Alosh B; Jazaerly T; Hayek K; Semaan A; Sood AK; Ali-Fehmi R
    Gynecol Oncol; 2013 Feb; 128(2):344-8. PubMed ID: 22871469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.